We are live on ! Find out more
BNTX icon

BioNTech

335 hedge funds and large institutions have $10B invested in BioNTech in 2021 Q3 according to their latest regulatory filings, with 88 funds opening new positions, 93 increasing their positions, 102 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

159% more first-time investments, than exits

New positions opened: 88 | Existing positions closed: 34

28% more capital invested

Capital invested by funds: $7.83B → $10B (+$2.17B)

18% more funds holding

Funds holding: 283335 (+52)

0.73% more ownership

Funds ownership: 14.65%15.39% (+0.73%)

0% more funds holding in top 10

Funds holding in top 10: 66 (0)

9% less repeat investments, than reductions

Existing positions increased: 93 | Existing positions reduced: 102

36% less call options, than puts

Call options by funds: $1.48B | Put options by funds: $2.32B

Holders
335
Holders Change
+52
Holders Change %
+18.37%
% of All Funds
5.86%
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.11%
New
88
Increased
93
Reduced
102
Closed
34
Calls
$1.48B
Puts
$2.32B
Net Calls
-$843M
Net Calls Change
-$492M
Name Holding Trade Value Shares
Change
Change in
Stake
RF
126
Robbins Farley
New Hampshire
$2.11M +$2.45M +7,721 New
CSS
127
Cubist Systematic Strategies
Connecticut
$2.08M -$728K -2,290 -23%
Invesco
128
Invesco
Georgia
$2.05M +$420K +1,323 +21%
PIM
129
Platinum Investment Management
Australia
$2.04M -$17.3M -54,567 -88%
BCM
130
Bayesian Capital Management
New York
$1.99M +$2.32M +7,300 New
BCM
131
Bronte Capital Management
Australia
$1.85M -$1.32M -4,168 -38%
KAS
132
Kestra Advisory Services
Texas
$1.82M +$1.83M +5,750 +624%
HCA
133
Harbour Capital Advisors
Virginia
$1.73M +$57.2K +180 +3%
YIH
134
Y-Intercept (HK)
Hong Kong
$1.71M +$1.99M +6,261 New
Ameriprise
135
Ameriprise
Minnesota
$1.68M +$1.41M +4,448 +178%
ECM
136
ExodusPoint Capital Management
New York
$1.6M +$701K +2,206 +61%
Baird Financial Group
137
Baird Financial Group
Wisconsin
$1.58M -$241K -758 -12%
SB
138
Samsara BioCapital
California
$1.57M
UCFA
139
United Capital Financial Advisors
Texas
$1.57M +$1.83M +5,747 New
EAM
140
Erste Asset Management
Austria
$1.52M -$3.02M -9,500 -63%
TLP
141
Tri Locum Partners
New York
$1.5M +$1.75M +5,506 New
NL
142
NVWM LLC
Pennsylvania
$1.48M +$42K +132 +3%
CCB
143
Cutter & Co Brokerage
Missouri
$1.47M -$345K -1,084 -17%
Nomura Holdings
144
Nomura Holdings
Japan
$1.47M +$1.68M +5,285 New
TRCT
145
Tower Research Capital (TRC)
New York
$1.42M -$3.17M -9,964 -66%
CC
146
Centiva Capital
New York
$1.34M +$1.24M +3,889 +380%
BAM
147
Blueshift Asset Management
New Jersey
$1.32M +$1.54M +4,831 New
BMSSC
148
B. Metzler seel. Sohn & Co
Germany
$1.31M -$2.7M -8,485 -63%
VHAM
149
Van Hulzen Asset Management
California
$1.31M +$346K +1,088 +29%
B
150
Barings
North Carolina
$1.31M +$779K +2,450 +104%

BNTX Hedge Fund Activity: Q3 2021 in Review

335 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in BioNTech (BNTX) for Q3 2021, worth a combined $10B — up 28% from $7.83B a quarter earlier.

Buyers outnumbered sellers: 88 funds opened new BNTX positions and 34 closed out — a net gain of 54 holders — while 93 added to existing stakes and 102 trimmed.

The largest buyer was Jennison Associates, adding an estimated $1.21B. The largest seller was Gates Foundation, cutting an estimated $283M.

  • 335 institutional investors held BioNTech (BNTX) as of Q3 2021, up from 283 in Q2 2021.
  • Funds reported $10B of BioNTech stock for Q3 2021, up 28% quarter-over-quarter.
  • 88 funds opened new BioNTech positions in Q3 2021 and 34 closed out, a net change of +54 holders.
  • The largest BioNTech buyer in Q3 2021 was Jennison Associates, an estimated $1.21B added.
  • The largest BioNTech seller in Q3 2021 was Gates Foundation, an estimated $283M sold.

Based on aggregated 13F filings for Q3 2021.